EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 99 filers reported holding EPIZYME INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $179,000 | -33.9% | 14,243 | 0.0% | 0.00% | -50.0% |
Q3 2017 | $271,000 | +13.4% | 14,243 | -10.2% | 0.00% | 0.0% |
Q2 2017 | $239,000 | -12.1% | 15,856 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $272,000 | +41.7% | 15,856 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $192,000 | +23.1% | 15,856 | 0.0% | 0.00% | +100.0% |
Q3 2016 | $156,000 | -3.7% | 15,856 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $162,000 | -15.6% | 15,856 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $192,000 | -24.4% | 15,856 | 0.0% | 0.00% | -33.3% |
Q4 2015 | $254,000 | +24.5% | 15,856 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $204,000 | -46.5% | 15,856 | 0.0% | 0.00% | -25.0% |
Q2 2015 | $381,000 | +27.9% | 15,856 | 0.0% | 0.00% | +33.3% |
Q1 2015 | $298,000 | -0.3% | 15,856 | 0.0% | 0.00% | -25.0% |
Q4 2014 | $299,000 | -30.5% | 15,856 | 0.0% | 0.00% | -33.3% |
Q3 2014 | $430,000 | -12.8% | 15,856 | 0.0% | 0.01% | -25.0% |
Q2 2014 | $493,000 | -29.9% | 15,856 | -48.6% | 0.01% | -38.5% |
Q1 2014 | $703,000 | – | 30,856 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |